471 related articles for article (PubMed ID: 26531137)
81. Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era.
Breimer ME
Xenotransplantation; 2011; 18(4):215-28. PubMed ID: 21848538
[TBL] [Abstract][Full Text] [Related]
82. Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.
Wigglesworth KM; Racki WJ; Mishra R; Szomolanyi-Tsuda E; Greiner DL; Galili U
J Immunol; 2011 Apr; 186(7):4422-32. PubMed ID: 21357545
[TBL] [Abstract][Full Text] [Related]
83. Alpha-Galactosyl trisaccharide epitope: Modification of the 6-primary positions and recognition by human anti-alphaGal antibody.
Andreana PR; Kowal P; Janczuk AJ; Wang PG
Glycoconj J; 2004; 20(2):107-18. PubMed ID: 15001843
[TBL] [Abstract][Full Text] [Related]
84. Expression of xenoantigen transformed human cancer cells to be susceptible to antibody-mediated cell killing.
Yoshimura N; Sawada T; Furusawa M; Fuchinoue S
Cancer Lett; 2001 Mar; 164(2):155-60. PubMed ID: 11179830
[TBL] [Abstract][Full Text] [Related]
85. Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.
Larkin JM; Porter CD
Cancer Immunol Immunother; 2007 Jan; 56(1):60-9. PubMed ID: 16715304
[TBL] [Abstract][Full Text] [Related]
86. Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes.
Abdel-Motal UM; Wang S; Awad A; Lu S; Wigglesworth K; Galili U
Vaccine; 2010 Feb; 28(7):1758-65. PubMed ID: 20034607
[TBL] [Abstract][Full Text] [Related]
87. The anti-nonGal xenoantibody response to alpha1,3-galactosyltransferase gene knockout pig xenografts.
Harnden I; Kiernan K; Kearns-Jonker M
Curr Opin Organ Transplant; 2010 Apr; 15(2):207-11. PubMed ID: 20075731
[TBL] [Abstract][Full Text] [Related]
88. The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation.
Tearle RG; Tange MJ; Zannettino ZL; Katerelos M; Shinkel TA; Van Denderen BJ; Lonie AJ; Lyons I; Nottle MB; Cox T; Becker C; Peura AM; Wigley PL; Crawford RJ; Robins AJ; Pearse MJ; d'Apice AJ
Transplantation; 1996 Jan; 61(1):13-9. PubMed ID: 8560551
[TBL] [Abstract][Full Text] [Related]
89. Intravenous synthetic alphaGal saccharides delay hyperacute rejection following pig-to-baboon heart transplantation.
Romano E; Neethling FA; Nilsson K; Kosanke S; Shimizu A; Magnusson S; Svensson L; Samuelsson B; Cooper DK
Xenotransplantation; 1999 Feb; 6(1):36-42. PubMed ID: 10355731
[TBL] [Abstract][Full Text] [Related]
90. Synthesis of alpha-Gal epitope derivatives with a galactosyltransferase-epimerase fusion enzyme.
Fang J; Chen X; Zhang W; Janczuk A; Wang PG
Carbohydr Res; 2000 Dec; 329(4):873-8. PubMed ID: 11125830
[TBL] [Abstract][Full Text] [Related]
91. Comparison of Gal and non-Gal-mediated cardiac xenograft rejection.
Tazelaar HD; Byrne GW; McGregor CG
Transplantation; 2011 May; 91(9):968-75. PubMed ID: 21403591
[TBL] [Abstract][Full Text] [Related]
92. First conjugation directed traverse of gene cassettes harboring α1,3GT from fast-growing Mycobacterium smegmatis mc
Golichenari B; Yari S; Tasbiti AH; Behravan J; Vaziri F; Ghazvini K
Enzyme Microb Technol; 2022 May; 156():110003. PubMed ID: 35149427
[TBL] [Abstract][Full Text] [Related]
93. Carbohydrate antigen expression and anti-pig antibodies in New World capuchin monkeys: Relevance to studies of xenotransplantation.
Li Q; Shaikh S; Iwase H; Long C; Lee W; Zhang Z; Wang Y; Ayares D; Cooper DKC; Hara H
Xenotransplantation; 2019 May; 26(3):e12498. PubMed ID: 30770572
[TBL] [Abstract][Full Text] [Related]
94. Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Gal alpha1,3Gal epitope.
Liu J; Qian Y; Holgersson J
Transplantation; 1997 Jun; 63(11):1673-82. PubMed ID: 9197365
[TBL] [Abstract][Full Text] [Related]
95. Synthesis of alpha-gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on human tumor cells by recombinant alpha1,3galactosyltransferase produced in Pichia pastoris.
Chen ZC; Tanemura M; Galili U
Glycobiology; 2001 Jul; 11(7):577-86. PubMed ID: 11447137
[TBL] [Abstract][Full Text] [Related]
96. Modifying the sugar icing on the transplantation cake.
Cooper DK
Glycobiology; 2016 Jun; 26(6):571-81. PubMed ID: 26935763
[TBL] [Abstract][Full Text] [Related]
97. In vivo neutralization of naturally existing antibodies against linear alpha(1,3)-galactosidic carbohydrate epitopes by multivalent antigen presentation: a solution for the first hurdle of pig-to-human xenotransplantation.
Duthaler RO; Ernst B; Fischer R; Katopodis AG; Kinzy W; Marterer W; Oehrlein R; Streiff MB; Thoma G
Chimia (Aarau); 2010; 64(1-2):23-8. PubMed ID: 21137679
[TBL] [Abstract][Full Text] [Related]
98. Secretion of alpha1,3-galactosyltransferase by cultured cells and presence of enzyme in animal sera.
Cho SK; Yeh JC; Cummings RD
Glycoconj J; 1997 Nov; 14(7):809-19. PubMed ID: 9511986
[TBL] [Abstract][Full Text] [Related]
99. Delayed rejection of porcine cartilage is averted by transgenic expression of alpha1,2-fucosyltransferase.
Costa C; Brokaw JL; Wang Y; Fodor WL
FASEB J; 2003 Jan; 17(1):109-11. PubMed ID: 12475900
[TBL] [Abstract][Full Text] [Related]
100. Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene.
Koike C; Friday RP; Nakashima I; Luppi P; Fung JJ; Rao AS; Starzl TE; Trucco M
Transplantation; 2000 Nov; 70(9):1275-83. PubMed ID: 11087141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
